V E Laubach Selected Research

V E Laubach Research Topics

4	Ischemia 09/2013 - 07/2000
4	Reperfusion Injury 09/2013 - 07/2000
3	Hypoxia (Hypoxemia) 09/2013 - 10/2000
2	Body Weight (Weight, Body) 08/2001 - 11/2000
1	Inflammation (Inflammations) 09/2013
1	Patent Ductus Arteriosus 05/2007
1	Spinal Cord Ischemia 09/2001
1	Paralysis (Palsy) 09/2001
1	Hyperplasia 08/2001
1	Pulmonary Hypertension 08/2001
1	Hypertrophy 08/2001
1	Vascular Remodeling 10/2000
1	Septic Shock (Toxic Shock Syndrome) 09/2000
1	Myocardial Stunning (Stunned Myocardium) 09/2000
1	Edema (Dropsy) 09/2000
1	Left Ventricular Dysfunction 07/2000
1	Ischemic Contracture 07/2000

3	Proteins (Proteins, Gene)FDA Link 08/2001 - 10/2000
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2000 - 07/2000
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 10/2000 - 09/2000
1	Receptor for Advanced Glycation End ProductsIBA 09/2013
1	HMGB1 Protein (HMG1)IBA 09/2013
1	Interleukin-17 (Interleukin 17)IBA 09/2013
1	endothelium-dependent hyperpolarization factor (EDHF)IBA 05/2007
1	Transaminases (Aminotransferases)IBA 11/2001
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2001
1	Adenosine (Adenocard)FDA LinkGeneric 09/2001
1	ATL 146eIBA 09/2001
1	Soluble Guanylyl CyclaseIBA 08/2001
1	DNA (Deoxyribonucleic Acid)IBA 08/2001
1	Nitric Oxide Synthase (NO Synthase)IBA 08/2001
1	ErbB Receptors (EGF Receptor)IBA 08/2001
1	gadolinium chlorideIBA 06/2001
1	Epidermal Growth Factor (EGF)IBA 11/2000
1	salicylhydroxamic acid (SHAM)IBA 11/2000
1	von Willebrand FactorIBA 10/2000
1	Actins (F Actin)IBA 10/2000
1	Vasoconstrictor AgentsIBA 09/2000
1	BuffersIBA 09/2000
1	Bicarbonates (Hydrogen Carbonate)IBA 09/2000
1	NF-kappa B (NF-kB)IBA 09/2000
1	prolinedithiocarbamate (PDTC)IBA 09/2000
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 07/2000

1	Warm Ischemia 11/2001
1	Lung Transplantation 06/2001
1	Pneumonectomy (Lung Volume Reduction) 11/2000
1	Thoracotomy 11/2000
1	Transplantation 09/2000
1	Therapeutics 09/2000